IXC 0.00% 7.0¢ invex therapeutics ltd

Ann: Notice of Investor Call and Presentation, page-94

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    Wouldn't as @IndexInvestor said the fact that generics aren't subsidised by insurers be enough of a financial incentive for patients to use Presendin? As well as the now added benefit of SR PT320
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $1.229K 17.55K

Buyers (Bids)

No. Vol. Price($)
2 50457 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 11.29am 19/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.